Zinger Key Points
- Aurora Cannabis Inc. and Willow Biosciences Inc. have completed a confidential settlement resolving the ongoing patent litigation.
- Aurora undertook the patent infringement action in July 2021.
- Get Monthly Picks of Market's Fastest Movers
Aurora Cannabis Inc. ACB ACB announced Tuesday that it had successfully completed a confidential settlement resolving an ongoing patent litigation with Willow Biosciences Inc. CANSF WLLW.
Aurora undertook the patent infringement action in July 2021, alleging that Willow's biosynthetic process for synthesizing cannabinoids infringed Aurora's exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council (NRC).
The technology of the asserted patents was invented by Anandia co-founder and former chief science officer at Aurora, Jonathan Page and his colleagues, following their work at the University of Saskatchewan and the NRC. They identified key enzymes and corresponding genes in the biosynthetic pathways of cannabis plants.
In December 2022, Willow announced that it had consolidated its R&D operations, transferring equipment and key personnel from its Canadian facilities to Mountain View, California.
"We are pleased with the negotiated settlement, which provides Aurora a favorable resolution that ensures our Canadian cannabis-related patent rights are respected," Miguel Martin, CEO of Aurora said. "Aurora is a pioneer in terms of the company's genetics work in the Canadian cannabis industry and will not hesitate to continue to take the steps necessary, including legal action, to protect and enforce our intellectual property rights when necessary."
ACB Price Action
Aurora’s shares traded 0.8728% higher at $0.4276 per share at the time of writing on Tuesday morning.
Did you miss the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth. Join Benzinga PotProfits. Benefit from Michael Berger’s sharp analysis, revealing top cannabis stock opportunities and timely updates. Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now, before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.
Related News
- Aurora And Curaleaf Cannabis Companies Each Close Multi-Million Dollar Funding Deals
- Aurora Stock Plunges On $25M Bought Deal To Repay Convertible Debt
- Aurora Cannabis Launches New Brand At Toronto Hall of Flowers, This Is What Innovation Looks Like
Photo: Courtesy of succo, mrkukuruznik5 by Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.